BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22648373)

  • 1. Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.
    Chen LS; Baker TB; Piper ME; Breslau N; Cannon DS; Doheny KF; Gogarten SM; Johnson EO; Saccone NL; Wang JC; Weiss RB; Goate AM; Bierut LJ
    Am J Psychiatry; 2012 Jul; 169(7):735-42. PubMed ID: 22648373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics and personalized medicine:
    Chen LS; Bierut LJ
    J Food Drug Anal; 2013 Dec; 21(4):S87-S90. PubMed ID: 25214750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.
    Culverhouse RC; Chen LS; Saccone NL; Ma Y; Piper ME; Baker TB; Bierut LJ
    Nicotine Tob Res; 2020 Feb; 22(2):248-255. PubMed ID: 30882151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence.
    Lee SH; Ahn WY; Seweryn M; Sadee W
    BMC Genomics; 2018 Nov; 19(1):826. PubMed ID: 30453884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.
    Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Schatzberg AF; Murphy GM
    Am J Med Genet B Neuropsychiatr Genet; 2011 Apr; 156B(3):275-84. PubMed ID: 21268243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.
    Barrie ES; Hartmann K; Lee SH; Frater JT; Seweryn M; Wang D; Sadee W
    Hum Mutat; 2017 Jan; 38(1):112-119. PubMed ID: 27758088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.
    Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Ameli N; Schatzberg AF; Murphy GM
    Nicotine Tob Res; 2015 Sep; 17(9):1126-33. PubMed ID: 25572450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
    Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
    BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance.
    Winterer G; Mittelstrass K; Giegling I; Lamina C; Fehr C; Brenner H; Breitling LP; Nitz B; Raum E; Müller H; Gallinat J; Gal A; Heim K; Prokisch H; Meitinger T; Hartmann AM; Möller HJ; Gieger C; Wichmann HE; Illig T; Dahmen N; Rujescu D
    Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1448-58. PubMed ID: 20886544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population.
    Pérez-Morales R; González-Zamora A; González-Delgado MF; Calleros Rincón EY; Olivas Calderón EH; Martínez-Ramírez OC; Rubio J
    Ann Hum Genet; 2018 Nov; 82(6):415-424. PubMed ID: 29993116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.
    Tyndale RF; Zhu AZ; George TP; Cinciripini P; Hawk LW; Schnoll RA; Swan GE; Benowitz NL; Heitjan DF; Lerman C;
    PLoS One; 2015; 10(5):e0128109. PubMed ID: 26010901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association and cis-mQTL analysis of variants in CHRNA3-A5, CHRNA7, CHRNB2, and CHRNB4 in relation to nicotine dependence in a Chinese Han population.
    Liu Q; Han H; Wang M; Yao Y; Wen L; Jiang K; Ma Y; Fan R; Chen J; Su K; Yang Z; Cui W; Yuan W; Jiang X; Li J; Payne TJ; Wang J; Li MD
    Transl Psychiatry; 2018 Apr; 8(1):83. PubMed ID: 29666375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.
    Bloom AJ; Hartz SM; Baker TB; Chen LS; Piper ME; Fox L; Martinez M; Hatsukami D; Johnson EO; Laurie CC; Saccone NL; Goate A; Bierut LJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1003-10. PubMed ID: 25072098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans.
    Saccone NL; Wang JC; Breslau N; Johnson EO; Hatsukami D; Saccone SF; Grucza RA; Sun L; Duan W; Budde J; Culverhouse RC; Fox L; Hinrichs AL; Steinbach JH; Wu M; Rice JP; Goate AM; Bierut LJ
    Cancer Res; 2009 Sep; 69(17):6848-56. PubMed ID: 19706762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility.
    Zhang H; Kranzler HR; Poling J; Gelernter J
    Neuropsychopharmacology; 2010 Oct; 35(11):2211-24. PubMed ID: 20631687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans.
    Li MD; Xu Q; Lou XY; Payne TJ; Niu T; Ma JZ
    Am J Med Genet B Neuropsychiatr Genet; 2010 Apr; 153B(3):745-56. PubMed ID: 19859904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of genetic risk (CHRNA5) and environmental risk (partner smoking) on cigarette smoking reduction.
    Chen LS; Baker TB; Piper ME; Smith SS; Gu C; Grucza RA; Smith GD; Munafo M; Bierut LJ
    Drug Alcohol Depend; 2014 Oct; 143():36-43. PubMed ID: 25073833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.
    Chen LS; Baker TB; Jorenby D; Piper M; Saccone N; Johnson E; Breslau N; Hatsukami D; Carney RM; Bierut LJ
    Drug Alcohol Depend; 2015 Sep; 154():278-82. PubMed ID: 26142345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population.
    Li MD; Yoon D; Lee JY; Han BG; Niu T; Payne TJ; Ma JZ; Park T
    PLoS One; 2010 Aug; 5(8):e12183. PubMed ID: 20808433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers.
    Halldén S; Sjögren M; Hedblad B; Engström G; Hamrefors V; Manjer J; Melander O
    J Intern Med; 2016 Apr; 279(4):388-98. PubMed ID: 26689306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.